122 related articles for article (PubMed ID: 2617462)
1. Extrinsic coagulation pathway inhibitor during recombinant factor VIIa infusion.
Sandset PM; Abildgaard U; Hedner U; Johansson H
Thromb Haemost; 1989 Dec; 62(4):1146. PubMed ID: 2617462
[No Abstract] [Full Text] [Related]
2. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
Sandset PM; Abildgaard U
Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
[TBL] [Abstract][Full Text] [Related]
4. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
[TBL] [Abstract][Full Text] [Related]
5. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
Lormeau JC; Herault JP; Herbert JM
Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
[TBL] [Abstract][Full Text] [Related]
7. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
[TBL] [Abstract][Full Text] [Related]
8. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Curr Stud Hematol Blood Transfus; 1991; (58):22-5. PubMed ID: 1954769
[No Abstract] [Full Text] [Related]
10. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
Morrissey JH
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
12. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Warn-Cramer BJ; Almus FE; Rapaport SI
Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
[TBL] [Abstract][Full Text] [Related]
13. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
Rapaport SI
Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
[No Abstract] [Full Text] [Related]
14. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients.
Lindahl AK; Abildgaard U; Stokke G
Thromb Res; 1990 Aug; 59(3):651-6. PubMed ID: 2237832
[No Abstract] [Full Text] [Related]
15. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
Nordfang O; Valentin S; Beck TC; Hedner U
Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation and fibrinolysis: an overview.
Mosher DF
Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
[TBL] [Abstract][Full Text] [Related]
17. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
18. Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2.
Girard TJ; McCourt D; Novotny WF; MacPhail LA; Likert KM; Broze GJ
Biochem J; 1990 Sep; 270(3):621-5. PubMed ID: 2122883
[TBL] [Abstract][Full Text] [Related]
19. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
Kondo S; Kisiel W
Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
[TBL] [Abstract][Full Text] [Related]
20. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
